GMP: New FDA Guideline on Size, Shape and Physical Attributes of Generics

The FDA published a guideline draft entitled \"Size, Shape, and Other Physical Attributes of Generic Tablets and Capsules\". The Agency saw a need for regulation because of the fact that the dosage forms of generics - particularly tablets and capsules - may considerably differ in shape and size from reference listed drugs (RLD) despite of equivalent pharmacological parameters.